Mediar Therapeutics
Michael Choi is on the Scientific Advisory Board at Mediar Therapeutics. Michael is also an Assistant Professor of Medicine at Harvard Medical School.
This person is not in the org chart
This person is not in any offices
Mediar Therapeutics
Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.